ARBUTUS BIOPHARMA CORP's ticker is ABUS and the CUSIP is 03879J100. A total of 97 filers reported holding ARBUTUS BIOPHARMA CORP in Q3 2023. The put-call ratio across all filers is 0.90 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2018 | $1,318,000 | +46.0% | 180,582 | 0.0% | 0.01% | +25.0% |
| Q1 2018 | $903,000 | -1.0% | 180,582 | 0.0% | 0.01% | 0.0% |
| Q4 2017 | $912,000 | -18.6% | 180,582 | 0.0% | 0.01% | -11.1% |
| Q3 2017 | $1,120,000 | +72.3% | 180,582 | 0.0% | 0.01% | +50.0% |
| Q2 2017 | $650,000 | +10.7% | 180,582 | 0.0% | 0.01% | +20.0% |
| Q1 2017 | $587,000 | +32.8% | 180,582 | 0.0% | 0.01% | +25.0% |
| Q4 2016 | $442,000 | -28.8% | 180,582 | 0.0% | 0.00% | -33.3% |
| Q3 2016 | $621,000 | -1.1% | 180,582 | 0.0% | 0.01% | -14.3% |
| Q2 2016 | $628,000 | -15.8% | 180,582 | 0.0% | 0.01% | -12.5% |
| Q1 2016 | $746,000 | -7.2% | 180,582 | 0.0% | 0.01% | +14.3% |
| Q4 2015 | $804,000 | -26.9% | 180,582 | 0.0% | 0.01% | -30.0% |
| Q3 2015 | $1,100,000 | – | 180,582 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Whitefort Capital Management, LP | 11,895,477 | $24,147,818 | 12.66% |
| Two Seas Capital LP | 8,280,818 | $16,810,061 | 3.38% |
| FourWorld Capital Management LLC | 1,341,907 | $2,724,071 | 0.51% |
| Tejara Capital Ltd | 180,077 | $365,556 | 0.21% |
| Woodline Partners LP | 4,719,903 | $9,581,403 | 0.11% |
| Hudson Bay Capital Management LP | 8,299,808 | $16,848,610 | 0.07% |
| Kepos Capital LP | 155,691 | $316 | 0.06% |
| Virtus ETF Advisers LLC | 40,040 | $81,281 | 0.05% |
| Centiva Capital, LP | 1,071,705 | $2,175,561 | 0.05% |
| Kades & Cheifetz LLC | 20,000 | $40,600 | 0.03% |